Testing effectiveness (Phase 2)Looking for participantsNCT07124078
What this trial is testing
Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 60